David Goldstein, Chief Scientific Officer at Principia Biopharma Inc. (PRNB), sold 10,000 shares at $32.39 ($324K) on 2019-11-07, disclosed to the SEC on 2019-11-08.
Open-market sale of $324k PRNB by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.